PD-L1 Inhibitors: Interview with Dr. Evan Alley of UPENN, about a new mesothelioma clinical trial
Update: 2014-05-19
Description
On May 14, 2014, at 8 PM Eastern time, the Mesothelioma Applied Research Foundation will be holding a new installment of its “Meet the Mesothelioma Experts” series featuring Dr. Evan Alley of the University of Pennsylvania, who will discuss his new clinical trial available to pleural mesothelioma patients. The clinical trial will look into an agent that would inhibit the PD-L1 protein. Read more on our blog.
Dr. Alley will discuss trial details in an interview with Mary Hesdorffer, Meso Foundation’s executive director and expert mesothelioma nurse practitioner. The interview can be listened to “live” by calling into a conference-call number.
Dr. Alley is part of the Penn Mesothelioma and Pleural Program team and the interim chief of the Division of Hematology and Medical Oncology at Penn Presbyterian Medical Center. Made possible by a generous educational grant provided by The Edgar Lomax Company.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
